Journal article
Is it possible to define resistance to acetylsalicylic acid and P2Y12 blockers at the patient's bedside?
Abstract
Multiple assays exist to measure antiplatelet effects of acetylsalicylic acid and clopidogrel, and numerous studies have demonstrated an association between incomplete inhibition with these drugs and risk of cardiovascular events. Simple point-of-care assays are potentially suitable for bedside use, and cutoffs for antiplatelet drug "resistance" diagnosis have been proposed. However, many assays remain poorly standardized and validated, …
Authors
Eikelboom JW; Hankey GJ
Journal
Dialogues in Cardiovascular Medicine, Vol. 16, No. 1, pp. 21–48
Publication Date
September 5, 2011
ISSN
1272-9949